Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

MT 7529

Next Previous
Search
Drug Profile

MT 7529

Alternative Names: H7 vaccine; H7 VLP influenza vaccine - Medicago; H7N9 vaccine - Medicago; H7N9 VLP vaccine with GLA adjuvant - Medicago; MT-7529; Plant-based H7N9 VLP vaccine - Medicago; Plant-made H7 virus-like particle influenza vaccine - Medicago

Latest Information Update: 17 Feb 2023

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Medicago
  • Class Influenza A virus H7N9 vaccines; Virus-like particle vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Discontinued Influenza A virus H7N9 subtype

Most Recent Events

  • 17 Feb 2023 Discontinued - Phase-I for Influenza A virus H7N9 subtype (Prevention) in Canada (IM) (Mitsubishi Tanabe Pharma Corporation pipeline, February 2023)
  • 22 Oct 2021 Phase-I development is still ongoing in Influenza-A virus H7N9 subtype (Prevention) in Canada (IM,Injection) (Mitsubishi Tanabe Pharmaceutical's pipeline, October 2021)
  • 28 Aug 2021 No recent reports of development identified for phase-I development in Influenza-A virus H7N9 subtype(Prevention) in Canada (IM, Injection)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top